跳至主要内容
临床试验/NCT04591847
NCT04591847已完成3 期

Pregnancy Outcomes and Vitamin D Level Among Vitamin D Supplementation During Pregnancy : A Double-blind Randomized Placebo Controlled Trial

Rajavithi Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年10月19日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Serum 25-OH vitamin D level in pregnant women

研究概览

简要总结

To compared pregnancy outcome (Serum vitamin D level in mother and infant , preeclampsia rate, preterm birth rate, Infant birth weight, Infant length , APGAR score) between pregnant women who were given vitamin D supplementation and pregnant women who were given placebo

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Thai female
  • Singleton pregnancy
  • Age at 18 years old or more
  • Gestational age at 18-22 weeks
  • Accept to enroll

排除标准

  • Pregnant women who not planned to delivery at Rajavithi hospital
  • Abnormal kidney function
  • Use antiepileptic drugs , or vitamin D supplementation
  • Allergy to vitamin D
  • Who were diagnosed as vitamin D deficiency

研究组 & 干预措施

Vitamin D supplemented group

Experimental

Vitamin D2 20000 IU 1 tab oral weekly start at GA 18 -22 weeks until delivery

干预措施: Vitamin D 2 (Drug)

Placebo group

Experimental

Placebo drug (Appearance same as Vitamin D2) 1 tab oral weekly start at GA 18 -22 weeks until delivery

干预措施: Placebo drug (Drug)

结局指标

主要结局

Serum 25-OH vitamin D level in pregnant women

时间窗: At delivery time

measure in nmol/L

Serum 25-OH vitamin D level in umbilicalcord blood

时间窗: At delivery time

measure in nmol/L

次要结局

  • Preeclampsia(During pregnancy until delivery)
  • Preterm birth(At delivery time)
  • Infant APGAR score(At delivery time)
  • Infant birth weight(At delivery time)
  • Infant length(At delivery time)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验